Advances in the Treatment of Epilepsy and Other Important Research Findings Andrew N. Wilner, MD, FAAN, FACP
•
Advances in Pediatric Epilepsy Martina Bebin, MD, MPA
•
Considerations for Women With Epilepsy Andrew N. Wilner, MD, FAAN, FACP
New Data on Depression and Epilepsy
CME/CEDepression in Epilepsy: A New Look at This Disorder Physicians - maximum of 0.5 AMA PRA Category 1 credit(s)™ Nurses - 0.5 nursing contact hours (0.25 of these credits are in the area of pharmacology)
Implantable Device Shows Promise in Refractory Epilepsy12/15/06 [Medscape Medical News] An implantable neurostimulator that detects the onset of seizures and interrupts them by delivering a small electrical discharge is showing promise in adults with medically refractory partial epilepsy.
Experimental Agent Shows Promise as Safe, Effective Antiepileptic12/07/06 [Medscape Medical News] An experimental agent is showing promise as an effective and safe replacement for the ketogenic diet and may pave the way for a new class of drugs to treat temporal lobe epilepsy, a new study suggests.
Mandatory Generic Substitution of Antiepileptic Drugs Raises Concerns12/05/06 [Medscape Medical News] Mandatory generic substitution of antiepileptic drugs is raising concerns among physicians and patients that this increasingly common practice is causing a rise in breakthrough seizures and subsequent adverse effects, 2 new studies suggest.
The materials presented here were prepared by independent authors under the editorial supervision of Medscape and do not represent a publication of the North American Regional Epilepsy Congress. These materials and the related activity are not sanctioned by the North American Regional Epilepsy Congress or the commercial supporter of the conference and do not constitute an official part of that conference.
The materials presented here do not reflect the views of Medscape or the companies providing unrestricted educational grants. These materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. All readers or continuing education participants should verify all information and data before treating patients or employing any therapies described in this educational activity.
